Daniel H. Schanne

1.4k total citations · 1 hit paper
19 papers, 860 citations indexed

About

Daniel H. Schanne is a scholar working on Pulmonary and Respiratory Medicine, Otorhinolaryngology and Genetics. According to data from OpenAlex, Daniel H. Schanne has authored 19 papers receiving a total of 860 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 6 papers in Otorhinolaryngology and 5 papers in Genetics. Recurrent topics in Daniel H. Schanne's work include Lung Cancer Diagnosis and Treatment (6 papers), Head and Neck Cancer Studies (5 papers) and Advanced Radiotherapy Techniques (4 papers). Daniel H. Schanne is often cited by papers focused on Lung Cancer Diagnosis and Treatment (6 papers), Head and Neck Cancer Studies (5 papers) and Advanced Radiotherapy Techniques (4 papers). Daniel H. Schanne collaborates with scholars based in Switzerland, Germany and United States. Daniel H. Schanne's co-authors include Matthias Gückenberger, Marta Scorsetti, Coen Hurkmans, Umberto Ricardi, Laurence Collette, André Dekker, Anne‐Marie C. Dingemans, Béatrice Fournier, Alejandra Romero and Dirk Verellen and has published in prestigious journals such as Blood, Cancer Research and The Lancet Oncology.

In The Last Decade

Daniel H. Schanne

18 papers receiving 854 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation

2020 631 citations Matthias Gückenberger, Yolande Lievens et al. The Lancet Oncology profile →

Peers

Daniel H. Schanne

PRM

ONCOL

RNMI

RADIA

SURGE

L. Caravatta Italy

Lucia Di Brina Italy

Keith Unger United States

Alessia Surgo Italy

Alessio Bruni Italy

Gabriele Reinartz Germany

Gianluca Ingrosso Italy

Shuichi Kanamori Japan

Luca Nicosia Italy

Eleni Gkika Germany

L. Caravatta Italy

Daniel H. Schanne

325 ×0.6

PRM

418 ×1.3

ONCOL

226 ×0.9

RNMI

256 ×1.4

RADIA

284 ×1.6

SURGE

Citations per year, relative to Daniel H. Schanne Daniel H. Schanne (= 1×) peers L. Caravatta

Countries citing papers authored by Daniel H. Schanne

Since Specialization

Citations

This map shows the geographic impact of Daniel H. Schanne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel H. Schanne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel H. Schanne more than expected).

Fields of papers citing papers by Daniel H. Schanne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel H. Schanne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel H. Schanne. The network helps show where Daniel H. Schanne may publish in the future.

Co-authorship network of co-authors of Daniel H. Schanne

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel H. Schanne. A scholar is included among the top collaborators of Daniel H. Schanne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel H. Schanne. Daniel H. Schanne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Eliçin, Olgun, et al.. (2025). Does omitting the clinical target volume in stereotactic radiotherapy for NSCLC affect oncologic outcomes? A retrospective analysis. Radiotherapy and Oncology. 211. 111092–111092.

Eliçin, Olgun, et al.. (2024). Predictive biomarkers of radiotherapy- related dermatitis, xerostomia, mucositis and dysphagia in head and neck cancer: A systematic review. Radiotherapy and Oncology. 203. 110689–110689. 2 indexed citations

Hool, Sara‐Lynn, et al.. (2024). Treatment and related morbidity of nasal cavity and paranasal sinus cancers. Frontiers in Oncology. 14. 1422892–1422892. 1 indexed citations

Schanne, Daniel H., et al.. (2024). Effect of dose to parotid ducts on Sticky Saliva and Xerostomia in radiotherapy of head and neck squamous cell carcinoma. Radiation Oncology. 19(1). 104–104. 1 indexed citations

Ochiai, Hiroki, Yoshinori Hoshino, Sebastian Klein, et al.. (2023). Inhibition of CXCR4 Enhances the Efficacy of Radiotherapy in Metastatic Prostate Cancer Models. Cancers. 15(4). 1021–1021. 8 indexed citations

Schanne, Daniel H., Olgun Eliçin, Roland Giger, et al.. (2022). Prognostic and Predictive Biomarkers in Head and Neck Squamous Cell Carcinoma Treated with Radiotherapy—A Systematic Review. Biomedicines. 10(12). 3288–3288. 5 indexed citations

Schanne, Daniel H., et al.. (2022). Stereotactic body radiotherapy for recurrent hemoptysis due to chronic pulmonary aspergillosis: a case report and systematic review of the literature. Strahlentherapie und Onkologie. 199(2). 192–200. 4 indexed citations

Eliçin, Olgun, Beat Bojaxhiu, Daniel H. Schanne, et al.. (2021). The prognostic impact of daytime and seasonality of radiotherapy on head and neck cancer. Radiotherapy and Oncology. 158. 293–299. 10 indexed citations

Čihorić, Nikola, Beat Bojaxhiu, Daniel H. Schanne, et al.. (2021). The impact of delivery daytime and seasonality of radiotherapy for head and neck cancer on toxicity burden. Radiotherapy and Oncology. 158. 162–166. 11 indexed citations

10.

Gückenberger, Matthias, Yolande Lievens, Laurence Collette, et al.. (2020). Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation. The Lancet Oncology. 21(1). e18–e28. 631 indexed citations breakdown →

11.

Mayinger, Michael, Johannes Kraft, Michael Weller, et al.. (2019). Leukoencephalopathy after prophylactic whole-brain irradiation with or without hippocampal sparing: a longitudinal magnetic resonance imaging analysis. European Journal of Cancer. 124. 194–203. 11 indexed citations

12.

Schanne, Daniel H., et al.. (2019). Evolution of treatment strategies for oligometastatic NSCLC patients – A systematic review of the literature. Cancer Treatment Reviews. 80. 101892–101892. 38 indexed citations

13.

Grahovac, Jelena, Shiwei Han, Hao Liu, et al.. (2019). Abstract B06: The angiotensin receptor blocker and partial PPARγ agonist telmisartan inhibits the growth of pancreatic ductal adenocarcinoma. Cancer Research. 79(24_Supplement). B06–B06. 1 indexed citations

14.

Peeken, Jan C., Jonas S. Jutzi, Julius Wehrle, et al.. (2018). Epigenetic regulation of NFE2 overexpression in myeloproliferative neoplasms. Blood. 131(18). 2065–2073. 35 indexed citations

15.

Chirindel, Alin, Sonja Adebahr, Tanja Schimek‐Jasch, et al.. (2015). Impact of 4D-18FDG-PET/CT imaging on target volume delineation in SBRT patients with central versus peripheral lung tumors. Multi-reader comparative study. Radiotherapy and Oncology. 115(3). 335–341. 31 indexed citations

16.

Schanne, Daniel H., Ursula Nestle, Michael Allgäuer, et al.. (2014). Stereotactic body radiotherapy for centrally located stage I NSCLC. Strahlentherapie und Onkologie. 191(2). 125–132. 43 indexed citations

17.

Maier, Patrick, et al.. (2014). The influence of retinoic Acid and thalidomide on the radiosensitivity of u343 glioblastoma cells.. PubMed. 34(4). 1885–91. 4 indexed citations

18.

Peeken, Jan C., Thalia S. Seeger, Julius Wehrle, et al.. (2013). Overexpression Of The Histone Demethylase JMJD1C In Polycythemia Vera Contributes To NF-E2 Overexpression Via Epigenetic Dysregulation and An Auto-Regulatory Loop. Blood. 122(21). 1602–1602. 2 indexed citations

19.

Mutschler, Manuel, Roland Roelz, Daniel H. Schanne, et al.. (2009). NF‐E2 overexpression delays erythroid maturation and increases erythrocyte production. British Journal of Haematology. 146(2). 203–217. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact